FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021008862> ?p ?o ?g. }

• W2021008862 endingPage "4591" @default.
• W2021008862 startingPage "4584" @default.
• W2021008862 abstract "ABSTRACT The first small-molecule CCR5 antagonist, TAK-779, could not be developed as an anti-human immunodeficiency virus type (anti-HIV-1) agent because of its poor oral bioavailability. TAK-652 is an orally bioavailable TAK-779 derivative with potent anti-HIV-1 activity. TAK-652 inhibited the binding of RANTES (regulated on activation, normal T-cell expressed and secreted), macrophage inflammatory protein 1α (MIP-1α), and MIP-1β to CCR5-expressing cells at nanomolar concentrations. TAK-652 could also suppress the binding of monocyte chemotactic protein 1 (MCP-1) to CCR2b-expressing cells. However, its inhibitory effect on ligand binding to other chemokine receptors was limited. TAK-652 was active against CCR5-using (R5) HIV-1 but totally inactive against CXCR4-using (X4) HIV-1. The compound was active against R5 HIV-1 clinical isolates containing reverse transcriptase and protease inhibitor-resistant mutations, with a mean 50% effective concentration (EC 50 ) and EC 90 of 0.061 and 0.25 nM, respectively. In addition, recombinant R5 viruses carrying different subtype (A to G) envelope proteins were equally susceptible to TAK-652. A single oral administration of TAK-652 up to 100 mg was safe and well tolerated in humans. The compound displayed favorable pharmacokinetics, and its plasma concentration was 7.2 ng/ml (9.1 nM) even 24 h after the administration of 25 mg. Thus, TAK-652 is a promising candidate as a novel entry inhibitor of HIV-1." @default.
• W2021008862 created "2016-06-24" @default.
• W2021008862 creator A5006326841 @default.
• W2021008862 creator A5006822602 @default.
• W2021008862 creator A5017342176 @default.
• W2021008862 creator A5031743046 @default.
• W2021008862 creator A5047861021 @default.
• W2021008862 creator A5080592581 @default.
• W2021008862 creator A5088292988 @default.
• W2021008862 creator A5090477990 @default.
• W2021008862 date "2005-11-01" @default.
• W2021008862 modified "2023-10-17" @default.
• W2021008862 title "TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans" @default.
• W2021008862 cites W1966261980 @default.
• W2021008862 cites W1966515400 @default.
• W2021008862 cites W2005980845 @default.
• W2021008862 cites W2006341180 @default.
• W2021008862 cites W2007021820 @default.
• W2021008862 cites W2021877795 @default.
• W2021008862 cites W2026444780 @default.
• W2021008862 cites W2043577582 @default.
• W2021008862 cites W2044004371 @default.
• W2021008862 cites W2046716698 @default.
• W2021008862 cites W2051785641 @default.
• W2021008862 cites W2057504223 @default.
• W2021008862 cites W2063825413 @default.
• W2021008862 cites W2090630729 @default.
• W2021008862 cites W2108256128 @default.
• W2021008862 cites W2124846613 @default.
• W2021008862 cites W2129875326 @default.
• W2021008862 cites W2135581465 @default.
• W2021008862 cites W2135739941 @default.
• W2021008862 cites W2135781036 @default.
• W2021008862 cites W2138758139 @default.
• W2021008862 cites W2140478082 @default.
• W2021008862 cites W2147169218 @default.
• W2021008862 cites W2148291080 @default.
• W2021008862 cites W2150792522 @default.
• W2021008862 cites W2161911309 @default.
• W2021008862 cites W2318289184 @default.
• W2021008862 cites W2916542119 @default.
• W2021008862 doi "https://doi.org/10.1128/aac.49.11.4584-4591.2005" @default.
• W2021008862 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1280155" @default.
• W2021008862 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16251299" @default.
• W2021008862 hasPublicationYear "2005" @default.
• W2021008862 type Work @default.
• W2021008862 sameAs 2021008862 @default.
• W2021008862 citedByCount "91" @default.
• W2021008862 countsByYear W20210088622012 @default.
• W2021008862 countsByYear W20210088622013 @default.
• W2021008862 countsByYear W20210088622014 @default.
• W2021008862 countsByYear W20210088622015 @default.
• W2021008862 countsByYear W20210088622016 @default.
• W2021008862 countsByYear W20210088622017 @default.
• W2021008862 countsByYear W20210088622018 @default.
• W2021008862 countsByYear W20210088622019 @default.
• W2021008862 countsByYear W20210088622020 @default.
• W2021008862 countsByYear W20210088622021 @default.
• W2021008862 countsByYear W20210088622022 @default.
• W2021008862 countsByYear W20210088622023 @default.
• W2021008862 crossrefType "journal-article" @default.
• W2021008862 hasAuthorship W2021008862A5006326841 @default.
• W2021008862 hasAuthorship W2021008862A5006822602 @default.
• W2021008862 hasAuthorship W2021008862A5017342176 @default.
• W2021008862 hasAuthorship W2021008862A5031743046 @default.
• W2021008862 hasAuthorship W2021008862A5047861021 @default.
• W2021008862 hasAuthorship W2021008862A5080592581 @default.
• W2021008862 hasAuthorship W2021008862A5088292988 @default.
• W2021008862 hasAuthorship W2021008862A5090477990 @default.
• W2021008862 hasBestOaLocation W20210088621 @default.
• W2021008862 hasConcept C112705442 @default.
• W2021008862 hasConcept C12823836 @default.
• W2021008862 hasConcept C13373296 @default.
• W2021008862 hasConcept C150903083 @default.
• W2021008862 hasConcept C159047783 @default.
• W2021008862 hasConcept C170493617 @default.
• W2021008862 hasConcept C181199279 @default.
• W2021008862 hasConcept C181389837 @default.
• W2021008862 hasConcept C185592680 @default.
• W2021008862 hasConcept C202751555 @default.
• W2021008862 hasConcept C207001950 @default.
• W2021008862 hasConcept C2522874641 @default.
• W2021008862 hasConcept C2776714187 @default.
• W2021008862 hasConcept C45635710 @default.
• W2021008862 hasConcept C55493867 @default.
• W2021008862 hasConcept C86803240 @default.
• W2021008862 hasConcept C98274493 @default.
• W2021008862 hasConceptScore W2021008862C112705442 @default.
• W2021008862 hasConceptScore W2021008862C12823836 @default.
• W2021008862 hasConceptScore W2021008862C13373296 @default.
• W2021008862 hasConceptScore W2021008862C150903083 @default.
• W2021008862 hasConceptScore W2021008862C159047783 @default.
• W2021008862 hasConceptScore W2021008862C170493617 @default.
• W2021008862 hasConceptScore W2021008862C181199279 @default.
• W2021008862 hasConceptScore W2021008862C181389837 @default.
• W2021008862 hasConceptScore W2021008862C185592680 @default.
• W2021008862 hasConceptScore W2021008862C202751555 @default.
• W2021008862 hasConceptScore W2021008862C207001950 @default.

• next